Related Experiment Video
Updated: Sep 17, 2025

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Breast cancer risk and screening for transgender and gender-diverse individuals
Dzhuliyan V Vasilev1, Juliana M Kling2, Evelyn F Carroll3
1Mayo Clinic Alix School of Medicine, Scottsdale, AZ.
Abstract:
Evidence from well-established studies of breast cancer risk in transgender and gender-diverse (TGD) people is lacking. As a result, current screening guidelines are based on extrapolation from cisgender populations, expert consensus, and retrospective cohort studies. Guideline recommendations focus on knowing patient baseline breast cancer risk and the risks associated with chosen gender-affirming hormone therapy and gender-affirming chest surgery. While existing guidelines are helpful, tailored protocols and research on effective breast cancer screening specific to TGD people are needed.
More Related Videos
Related Concept Videos
Cancer Prevention
Some...
Disorders of the Female Reproductive System

